CNBX PHARMACEUTICALS INC. (CNBX) Operating margin 2016–2024
CNBX PHARMACEUTICALS INC. (CNBX) operating margin by fiscal year — reported operating income divided by reported revenue.
-448.3%FY2024 · since FY2016: -249.5% → -448.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -448.3% | -221.2 pp |
| FY2023 | -227.1% | +9633.3 pp |
| FY2022 | -9860.4% | — |
| FY2020 | -42524.1% | -8961.1 pp |
| FY2019 | -33563.0% | +6107.1 pp |
| FY2018 | -39670.1% | -7054.0 pp |
| FY2017 | -32616.1% | -32366.6 pp |
| FY2016 | -249.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice